Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 3 open reading frame 56 pseudogene (ENSG00000259227) is a noncoding segment of DNA classified as a pseudogene, usually generated by the process of retrotransposition or gene duplication, and contains sequence homology to protein-coding genes but is generally nonfunctional[6][8]. Pseudogenes, including this one, are not involved in encoding functional proteins, usually lack key regulatory or coding sequences, and are not considered therapeutic targets. Newer studies suggest some pseudogenes can have RNA-level regulatory roles, but there is no evidence for such function in this particular sequence[3][5]. In summary, ENSG00000259227 is a nonfunctional processed pseudogene, not a therapeutic target, and not linked to protein function, disease, or drug interactions[6][8][3][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 3 open reading frame 56 pseudogene.